Evidence map›Paper›PMID 25061491›Full record

ArticlePrzeglad gastroenterologiczny2014

Preoperative glucose abnormalities in patients with pancreatic tumours.

Marta A Matejak-Górska, Marek Durlik, Bernadetta Kałuża, Alicja Milczarczyk, Edward Franek

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Przeglad gastroenterologiczny, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marta A Matejak-GórskaClinical Department of Gastroenterology Surgery and Transplantation, Central Clinical Hospital of Interior, Warsaw, Poland.
Marek DurlikClinical Department of Gastroenterology Surgery and Transplantation, Central Clinical Hospital of Interior, Warsaw, Poland ; Department of Surgical Research and Transplantology, Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw, Poland.
Bernadetta KałużaClinical Department of Internal Diseases, Endocrinology and Diabetology, Central Clinical Hospital of Interior, Warsaw, Poland.
Alicja MilczarczykClinical Department of Internal Diseases, Endocrinology and Diabetology, Central Clinical Hospital of Interior, Warsaw, Poland.
Edward FranekClinical Department of Internal Diseases, Endocrinology and Diabetology, Central Clinical Hospital of Interior, Warsaw, Poland ; Department of Human Epigenetics, Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPancreatic cancer is a neoplasm characterised by poor prognosis. The only effective, possible treatment is radical surgery, but most patients do not qualify for surgery because of delayed diagnosis.

aimTo determine if assessment of endocrine pancreatic function could serve as a means of screening for pancreatic cancer. MATERIAL AND

methodsThis prospective study was conducted on a group of 50 patients diagnosed with pancreatic tumour, who were qualified for surgery.

resultsFrom 1.07.2010 to 4.07.2011 a further 50 patients were added to the study group. They had been admitted to the hospital with pancreatic tumours. During the preoperative period, nine of these people had been treated for diabetes, 14 were newly diagnosed with diabetes and 15 had been diagnosed with impaired glucose tolerance, but only 12 had a normal glucose profile. Afterwards, patients underwent the surgical treatment. Histopathological examination revealed that out of the 50 operated patients, 36 suffered from malignant disease, and of these only four had no impaired glucose tolerance before treatment.

conclusionsIn most cases, patients with pancreatic tumours have impaired glucose tolerance. Screening patients over 50 years of age could speed up diagnosis and surgical treatment.

Indexed as

diabetespancreatic cancerpancreatic cancer screeningpancreatitisrisk factors for pancreatic cancersurgery

Identifiers

PMID25061491
PMCPMC4108753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.